Business Today

Catalyst of Change

LAURUS LABS, once a leading manufacturer of antiretroviral (ARV) drugs, is undergoing yet another transformation under Satyanarayana Chava, its Founder & CEO. Until 2011, ARVs—a group of medication used to manage and treat human immunodeficiency virus (HIV) infection—accounted for a substantial portion of the company’s revenue. Then it made a strategic shift towards becoming an active pharmaceutical ingredient (API)-focussed company.

Subsequently, the company forayed into the formulations business in 2014, which helped it become an integrated pharma company by 2020. As a result

You’re reading a preview, subscribe to read more.

More from Business Today

Business Today1 min read
All Guns Blazing
INDIA’S DEFENCE EXPORTS HAVE JUMPED ALMOST 31-FOLD TO A RECORD OF ₹21,083 CRORE IN FY24 FROM ₹686 CRORE IN FY14, REFLECTING THE COUNTRY’S GROWING CLOUT IN THE GLOBAL DEFENCE MANUFACTURING MARKET. WITH A ROBUST LOCAL MANUFACTURING ECOSYSTEM AND MORE T
Business Today2 min read
“Hire For Attitude, Not Ability”
Thryve Digital is a player in the healthcare technology sector delivering next-generation solutions What was the problem you were grappling with? When I decided to take on the challenge of setting up Thryve Digital, there wasn’t any industry referenc
Business Today2 min read
Silver Lining
SILVER PRICES SURGED to a fresh all-time high on the Multi Commodity Exchange (MCX), surpassing the ₹84,000 per kg milestone on April 12. The silver market has experienced significant fluctuations in recent quarters, driven by many factors, including

Related Books & Audiobooks